All In MedTech

FDA Clearance Tracker · P030054-S440

Promote/+/RF/Q, Promote Accel, Promote Quadra, Unify, Unify Assura, Unify Quadra, Quadra Assura, Epic+/HF/HF+/II HF/II+

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 21, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P030054-S440
Device name
Promote/+/RF/Q, Promote Accel, Promote Quadra, Unify, Unify Assura, Unify Quadra, Quadra Assura, Epic+/HF/HF+/II HF/II+
Applicant location
Sylmar, CA
Received
Dec 30, 2025
Decided
Jul 21, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P030054

Device type

Device class
Class III

Every decision under product code NIK

FDA's approval statement

As written in FDA's record.

approval for Merlin 2 Patient Care System (PCS) programmer support for the AVEIR Leadless Pacemakers.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.